
Sign up to save your podcasts
Or


This episode covers the hospital-at-home market through interviews with leaders from Mass General Brigham, Mayo Clinic, Advocate Health, and Mount Sinai, highlighting how programs are diversifying revenue beyond Medicare and finding strategic value despite not reaching financial breakeven. The episode also covers Walgreens' potential private equity deal with Sycamore Partners, Teladoc's stock drop amid AI-generated therapy allegations, and FTC Chair Andrew Ferguson's decision to maintain stricter merger guidelines from the Biden era.
This episode covers breaking news about NIH's steep cuts to indirect cost rates for universities and medical centers, potentially creating $100+ million shortfalls for major research institutions, though a federal court has temporarily blocked the cuts nationwide. The episode also discusses Trump's 46 executive orders affecting healthcare through immigration enforcement at hospitals, visa restrictions impacting foreign nurse recruitment, and tariff proposals, plus General Catalyst's expansion beyond VC into healthcare AI consulting and Cigna's new initiative linking executive pay to customer satisfaction measures.
This episode covers key insights from the J.P. Morgan Healthcare Conference, where non-profit health systems focused on operational efficiency, strategic growth in pediatrics and outpatient care, and AI investments, while enhanced security reflected the impact of the UnitedHealthcare CEO shooting. The episode also discusses rising bankruptcies among PE-owned healthcare companies, semaglutide being selected for Medicare drug price negotiations under the Trump administration, and new DEA rules that could challenge virtual-only telehealth models while benefiting hybrid care providers.
This episode covers insights from the 2024 Fall CFO Forum, where 41 health system CFOs discussed priorities now closely aligned with strategy leaders, including workforce strengthening, care delivery efficiencies, and improved access, along with debates over hard versus soft ROI measurements for AI deployments. The episode also covers Amazon One Medical facing a wrongful death lawsuit that could impact consumer perceptions of their healthcare brand, and includes 2025 healthcare predictions from industry leaders about increased M&A activity, rising healthcare misinformation challenges, and growth in tech-enabled benefits platforms.
This episode covers breaking news about Walgreens reportedly in talks to sell itself to private equity firm Sycamore Partners, which could provide needed cash but also create financial pressures leading to potential bankruptcy. The episode also discusses the Biden administration's proposed rule expanding Medicare and Medicaid coverage for GLP-1 weight loss drugs to 7.4 million additional beneficiaries at a $40 billion cost over 10 years, Trump's emerging healthcare team including RFK Jr. and Dr. Mehmet Oz, and Bain & Company's prediction that non-traditional players could still capture 30% of the primary care market by 2030 despite retail health setbacks.
Chief Physician Executives (CPEs) are uniquely positioned to bridge clinical care and strategic goals. In our latest Heard Around the C-Suite episode, we highlight insights from The Health Management Academy’s Fall 2024 CPE Forum, where CPEs shared their approaches to technology adoption, innovative workforce models, cybersecurity, and leadership development. This episode brings strategy executives into the room with CPEs, equipping them with practical insights to enhance collaboration with clinical leaders, align organizational goals, and implement solutions that drive both financial and clinical ROI.
Join Jerome Pagani, Executive Director of Strategy Catalyst, and Anika Rasheed, Strategy Catalyst Analyst, as they unpack key themes from the forum. The episode also includes clips from CPE Forum participants as they reflect on the innovations, strategies, and solutions discussed across the sessions.
Key Takeaways
This episode covers the CSO Forum in Phoenix, where health system executives discussed revenue diversification and capital constraints, with key insights on prioritizing strategic initiatives and segmented care models. The episode also covers Forward's sudden shutdown despite raising $100 million due to its unsustainable $149 monthly subscription model, and the DOJ's lawsuit blocking UnitedHealth Group's $3.3 billion Amedisys acquisition over antitrust concerns.
In today’s rapidly evolving healthcare landscape, health system CEOs have dozens of priorities on their plate—often simultaneously. While strategy leaders often work closely with their own CEOs, we wanted to bring you in the room to hear what CEOs from around the country are talking about and how they are grappling with their top priorities. Our inaugural audio episode of Heard Around the C-Suite dives into these challenges, recapping key insights from recent CEO discussions at The Health Management Academy’s CEO Forum and Horizon 2030 CEO Summit.
Listen in as Jerome Pagani, Executive Director of Strategy Catalyst, and Anika Rasheed, Strategy Catalyst Analyst, break down key themes from conversations with our resident experts and event attendees Robin Brand, Vice President of Member Insights, and Rebecca Akabas, Senior Director of Member Development.
Key Takeaways
This episode covers breaking news about Republican gains in recent elections potentially giving the GOP unified federal government control, which could impact healthcare policy on site-neutral payments, ACA reform, and public health initiatives. The episode also discusses Elevance Health's $2.7 billion acquisition of home health company CareBridge, the Sanford Health and Marshfield Clinic merger creating a $10+ billion system, and insights from the Health 2024 conference including PBM business model criticism and new AI standardization efforts.
This episode features an interview with Cone Health CSO Chris Cornue about the system's decision to join Risant Health, driven by their long-term shift into value-based care and their pluralistic physician model that gained buy-in from both employed and affiliated providers across 14 specialties. The episode also covers resumed merger talks between Humana and Cigna that could create the second-largest payer, declining CMS Medicare Advantage star ratings affecting 62% of beneficiaries, and retail pharmacy struggles including CVS CEO Karen Lynch stepping down and Walgreens closing 1,200 stores while facing massive healthcare services losses.
From the publisher's feed
The Strategy Catalyst Dispatch brings healthcare strategy professionals into the room with leading health system executives to explore how innovation, clinical leadership, and enterprise…